Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Neuroscience Research
|
September 1, 1993
Myelin basic protein mRNA translocation in oligodendrocytes is inhibited by astrocytes in vitro
S Amur-Umarjee, T Phan, A T Campagnoni
Developmental Neuroscience
|
January 1, 1997
Neuronal regulation of myelin basic protein mRNA translocation in oligodendrocytes is mediated by platelet-derived growth factor
S Amur-Umarjee, V Schonmann, A T Campagnoni
Clinical Pharmacology and Therapeutics
|
April 15, 2015
Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization
S Amur, L LaVange, I Zineh, et al.
Clinical Pharmacology and Therapeutics
|
August 24, 2007
The emerging role of pharmacogenomics in biologics
E LacanĂ¡, S Amur, P Mummanneni, et al.
Journal of Neuroendocrinology
|
March 1, 1995
5 beta-reductase and other androgen-metabolizing enzymes in primary cultures of developing zebra finch telencephalon
B A Schlinger, S Amur-Umarjee, A T Campagnoni, et al.
Clinical Pharmacology and Therapeutics
|
January 30, 2007
The experience with voluntary genomic data submissions at the FDA and a vision for the future of the voluntary data submission program
M S Orr, F Goodsaid, S Amur, et al.
Annals of the New York Academy of Sciences
|
January 1, 1990
Posttranscriptional events in the expression of myelin protein genes
A T Campagnoni, J M Verdi, A N Verity, et al.
Annals of the New York Academy of Sciences
|
January 1, 1991
Posttranscriptional regulation of myelin protein gene expression
A T Campagnoni, J M Verdi, A N Verity, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 1, 1994
Neuronal and non-neuronal aromatase in primary cultures of developing zebra finch telencephalon
B A Schlinger, S Amur-Umarjee, P Shen, et al.
Clinical Pharmacology and Therapeutics
|
February 12, 2015
Catalyzing the Critical Path Initiative: FDA's progress in drug development activities
A Parekh, S Buckman-Garner, S McCune, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Neuroscience Research
|
September 1, 1993
Myelin basic protein mRNA translocation in oligodendrocytes is inhibited by astrocytes in vitro
S Amur-Umarjee, T Phan, A T Campagnoni
Developmental Neuroscience
|
January 1, 1997
Neuronal regulation of myelin basic protein mRNA translocation in oligodendrocytes is mediated by platelet-derived growth factor
S Amur-Umarjee, V Schonmann, A T Campagnoni
Clinical Pharmacology and Therapeutics
|
April 15, 2015
Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization
S Amur, L LaVange, I Zineh, et al.
Clinical Pharmacology and Therapeutics
|
August 24, 2007
The emerging role of pharmacogenomics in biologics
E LacanĂ¡, S Amur, P Mummanneni, et al.
Journal of Neuroendocrinology
|
March 1, 1995
5 beta-reductase and other androgen-metabolizing enzymes in primary cultures of developing zebra finch telencephalon
B A Schlinger, S Amur-Umarjee, A T Campagnoni, et al.
Clinical Pharmacology and Therapeutics
|
January 30, 2007
The experience with voluntary genomic data submissions at the FDA and a vision for the future of the voluntary data submission program
M S Orr, F Goodsaid, S Amur, et al.
Annals of the New York Academy of Sciences
|
January 1, 1990
Posttranscriptional events in the expression of myelin protein genes
A T Campagnoni, J M Verdi, A N Verity, et al.
Annals of the New York Academy of Sciences
|
January 1, 1991
Posttranscriptional regulation of myelin protein gene expression
A T Campagnoni, J M Verdi, A N Verity, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 1, 1994
Neuronal and non-neuronal aromatase in primary cultures of developing zebra finch telencephalon
B A Schlinger, S Amur-Umarjee, P Shen, et al.
Clinical Pharmacology and Therapeutics
|
February 12, 2015
Catalyzing the Critical Path Initiative: FDA's progress in drug development activities
A Parekh, S Buckman-Garner, S McCune, et al.
Page
of 2